0001899924-21-000001.txt : 20211216
0001899924-21-000001.hdr.sgml : 20211216
20211216145902
ACCESSION NUMBER: 0001899924-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211216
DATE AS OF CHANGE: 20211216
EFFECTIVENESS DATE: 20211216
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: VIN-30 Neurexis Therapeutics, LLC
CENTRAL INDEX KEY: 0001899924
IRS NUMBER: 873578108
STATE OF INCORPORATION: AR
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-425358
FILM NUMBER: 211497526
BUSINESS ADDRESS:
STREET 1: 535 W. RESEARCH CENTER BLVD.
STREET 2: SUITE 135
CITY: FAYETTEVILLE
STATE: AR
ZIP: 72701
BUSINESS PHONE: 4795712592
MAIL ADDRESS:
STREET 1: 535 W. RESEARCH CENTER BLVD.
STREET 2: SUITE 135
CITY: FAYETTEVILLE
STATE: AR
ZIP: 72701
D
1
primary_doc.xml
X0708
D
LIVE
0001899924
VIN-30 Neurexis Therapeutics, LLC
535 W. RESEARCH CENTER BLVD.
SUITE 135
FAYETTEVILLE
AR
ARKANSAS
72701
4795712592
ARKANSAS
None
None
Limited Liability Company
true
2021
Robert
Calvin
Goforth
535 W. Research Center Blvd.
Suite 135
Fayetteville
AR
ARKANSAS
72701
Executive Officer
Director
CEO of Manager.
Other
Decline to Disclose
- 06b
false
2021-12-10
false
true
false
5000
None
None
None
None
N/A
N/A
Fayetteville
AR
ARKANSAS
72701
AR
ARKANSAS
NC
NORTH CAROLINA
TX
TEXAS
false
500000
45000
455000
false
5
0
0
0
false
VIN-30 Neurexis Therapeutics, LLC
Robert Calvin Goforth
Robert Calvin Goforth
CEO of Manager
2021-12-16